Fervo Energy (FRVO) has reportedly secured its largest power agreement to supply nearly 400MW of electricity to Google (GOOGL), WSJ reports
Newsquawk Staff ·
Fervo Energy (FRVO) has reportedly secured its largest power agreement to supply nearly 400MW of electricity to Google (GOOGL), WSJ reports.
What it means
Hyperscaler power purchase agreements have become a recurring feature of the US power complex as data centre load growth outpaces grid additions, and the pattern has been for each successive deal to be benchmarked against the last on size and on technology type. Geothermal PPAs of this scale sit at the large end of that sequence; most comparable agreements for firm, carbon-free supply have historically gone to nuclear or to gas with offsets, so an enhanced geothermal contract at several hundred megawatts tests whether the technology can move from pilot offtake to utility-scale commitment. The distinction that matters for the read-through is firm power versus intermittent: hyperscalers paying up for dispatchable clean supply signals the premium attached to around-the-clock load matching rather than annual renewable credits. Prior form from this buyer has been to seed emerging firm technologies with anchor contracts and then replicate across sites, so the follow-on tells are whether other hyperscalers sign comparable geothermal offtakes, whether the developer converts backlog into financed projects, and how regional power pricing and capacity markets in data centre corridors absorb the demand signal. The wire tags reference an automaker and index tags that do not match the subject; the note treats the headline text as authoritative.
Sources
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed
- US Treasury Secretary Bessent posts "... the United States is no longer managing the Iranian threat. We are ending it."
- IG Metall wants a conversation with Volkswagen (VOW3 GY) about job protection that extends into the 2030s; prepared to escalate conflict, including industrial actions
- Newsquawk Daily European Opening News - 23rd October 2026
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand
Related headlines
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce1 hour ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders1 hour ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer1 hour ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation2 hours ago
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM2 hours ago
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years3 hours ago
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months3 hours ago
- American Express (AXP) Q3 2026 (USD): EPS 5.42 (exp. 4.50), Revenue 20.1bln (exp. 20.1bln)4 hours ago
- Citi (C) has been granted approval by China for its securities unit6 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT16 hours ago
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated17 hours ago
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE18 hours ago
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)18 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone20 hours ago
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED22 hours ago